Transient power elevation during iron dextran infusion in a patient with a continuous-flow left ventricular assist device

Abstract

Anemia is common in patients with mechanical circulatory support and is associated with increased morbidity. Repletion using parenteral iron infusions has been proven to be beneficial in patients with heart failure. In this report, we describe a case of increased power and flows of continuous-flow left ventricular assist device (LVAD) during an iron dextran infusion. We subsequently studied the effects of iron dextran infusion in an in vitro LVAD mock circulatory loop. The observed increase in flow and power was most likely due to drug–patient interaction rather than drug–LVAD interaction. Mock loops and in vivo animal models may be necessary for proactive evaluation of the safety of intravenous (IV) preparations in this patient population.

Keywords

Iron dextran left ventricular assist device pharmacotherapy

Get full access to this article

View all access options for this article.

References

Jennings

Wagner

et al . Epidemiology and outcomes associated with anemia during long-term support with continuous-flow left ventricular assist devices. J Card Fail 2014; 20(6): 387–391.

Vrtovec

Radovancevic

Delgado

et al . Significance of anaemia in patients with advanced heart failure receiving long-term mechanical circulatory support. Eur J Heart Fail 2009; 11(10): 1000–1004.

Amione-Guerra

Cruz-Solbes

Bhimaraj

et al . Iron deficiency is the most common cause of anemia in CF-LVAD patients. J Cardiac Fail 2016; 22(8): S114

Draper

Huang

Gerson

LB.

GI bleeding in patients with continuous-flow left ventricular assist devices: a systematic review and meta-analysis. Gastrointest Endosc 2014; 80(3): 435–446.e1.

Lewis

Semigran

Givertz

et al . Oral iron therapy for heart failure with reduced ejection fraction: design and rationale for oral iron repletion effects on oxygen uptake in heart failure. Circ Heart Fail 2016; 9(5): e000345.

Szebeni

Fishbane

Hedenus

et al . Hypersensitivity to intravenous iron: classification, terminology, mechanisms and management. Br J Pharmacol 2015; 172(21): 5025–5036.

Simons

Ardusso

Bilo

et al . World allergy organization guidelines for the assessment and management of anaphylaxis. World Allergy Organ J 2011; 4(2): 13–37.

Rampton

Folkersen

Fishbane

et al . Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management. Haematologica 2014; 99(11): 1671–1676.

Plouraboue

Cloetens

Fonta

et al . X-ray high-resolution vascular network imaging. J Microsc 2004; 215(Pt 2): 139–148.

10.

Maltais

Kilic

Nathan

et al . PREVENtion of HeartMate II Pump Thrombosis Through Clinical Management: The PREVENT multi-center study. J Heart Lung Transplant 2017; 36(1): 1–12.